Association of an intronic, but not any exonic, FRMD4B sequence variant and heart failure
- PMID: 20718813
- PMCID: PMC2925316
- DOI: 10.1111/j.1752-8062.2010.00220.x
Association of an intronic, but not any exonic, FRMD4B sequence variant and heart failure
Abstract
Common forms of heart failure (HF) exhibit familial clustering, but specific genetic risk factors have been challenging to identify. A recent single-nucleotide polymorphism (SNP) microarray study implicated a locus within an intron of FRMD4B in Caucasian HF. Here, we used next-generation resequencing of pooled DNA and individual Sequenom genotyping to test for associations between FRMD4B SNPs and ischemic and/or nonischemic cardiomyopathy in two independent populations. Exonic resequencing of Caucasians and African-Americans identified 32 FRMD4B SNPs, 13 of which had allele frequencies greater than 1%. None of these common FRMD4B SNPs were significantly associated with ischemic, nonischemic, or all-cause HF in either of the study populations. We individually genotyped the seminal intronic rs6787362 FRMD4B SNP in the primary study population and compared genotypes between HF cases and controls. The rs6787362 variant allele was more frequent in Caucasians with ischemic cardiomyopathy, and carriers (heterozygous or homozygous) of the variant allele had increased risk of HF (OR 1.437, CI 1.085-1.904; p= 0.0118). No such association was seen for African-American HF. These results confirm an association between the intronic rs6787362 FRMD4B SNP and ischemic cardiomyopathy in a European-derived population, but do not support the proposition that coding FRMD4B variants are susceptibility factors in common HF.
Figures

Similar articles
-
Common variants in HSPB7 and FRMD4B associated with advanced heart failure.Circ Cardiovasc Genet. 2010 Apr;3(2):147-54. doi: 10.1161/CIRCGENETICS.109.898395. Epub 2010 Feb 2. Circ Cardiovasc Genet. 2010. PMID: 20124441 Free PMC article.
-
Targeted deep resequencing identifies coding variants in the PEAR1 gene that play a role in platelet aggregation.PLoS One. 2013 May 21;8(5):e64179. doi: 10.1371/journal.pone.0064179. Print 2013. PLoS One. 2013. PMID: 23704978 Free PMC article.
-
Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals.JAMA Cardiol. 2018 Oct 1;3(10):929-938. doi: 10.1001/jamacardio.2018.2541. JAMA Cardiol. 2018. PMID: 30140897 Free PMC article.
-
Genetic contribution to variable human CYP3A-mediated metabolism.Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94. doi: 10.1016/s0169-409x(02)00066-2. Adv Drug Deliv Rev. 2002. PMID: 12406645 Review.
-
The Genetic Factors Influencing Cardiomyopathies and Heart Failure across the Allele Frequency Spectrum.J Cardiovasc Transl Res. 2024 Oct;17(5):1119-1139. doi: 10.1007/s12265-024-10520-y. Epub 2024 May 21. J Cardiovasc Transl Res. 2024. PMID: 38771459 Free PMC article. Review.
Cited by
-
A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.Elife. 2023 Nov 1;12:e84235. doi: 10.7554/eLife.84235. Elife. 2023. PMID: 37910431 Free PMC article.
-
Association of BTLA Polymorphisms with Susceptibility to Non-Small-Cell Lung Cancer in the Chinese Population.Biomed Res Int. 2021 Jan 29;2021:9121824. doi: 10.1155/2021/9121824. eCollection 2021. Biomed Res Int. 2021. PMID: 33564688 Free PMC article.
-
Systems genetics of obesity in an F2 pig model by genome-wide association, genetic network, and pathway analyses.Front Genet. 2014 Jul 9;5:214. doi: 10.3389/fgene.2014.00214. eCollection 2014. Front Genet. 2014. PMID: 25071839 Free PMC article.
References
-
- Richard P, Villard E, Charron P, Isnard R. The genetic bases of cardiomyopathies. J Am Coll Cardiol. 2006; 48: A79–A89.
-
- Larson MG, Atwood LD, Benjamin EJ, Cupples LA, D’Agostino RB Sr, Fox CS, Govindaraju DR, Guo CY, Heard‐Costa NL, Hwang SJ, Murabito JM, Newton‐Cheh C, O’Donnell CJ, Seshadri S, Vasan RS, Wang TJ, Wolf PA, Levy D. Framingham Heart Study 100K project: genome‐wide associations for cardiovascular disease outcomes. BMC Med Genet. 2007; 8(Suppl 1): S5. - PMC - PubMed
-
- Vasan RS, Glazer NL, Felix JF, Lieb W, Wild PS, Felix SB, Watzinger N, Larson MG, Smith NL, Dehghan A, Grosshennig A, Schillert A, Teumer A, Schmidt R, Kathiresan S, Lumley T, Aulchenko YS, Konig IR, Zeller T, Homuth G, Struchalin M, Aragam J, Bis JC, Rivadeneira F, Erdmann J, Schnabel RB, Dorr M, Zweiker R, Lind L, Rodeheffer RJ, Greiser KH, Levy D, Haritunians T, Deckers JW, Stritzke J, Lackner KJ, Volker U, Ingelsson E, Kullo I, Haerting J, O’Donnell CJ, Heckbert SR, Stricker BH, Ziegler A, Reffelmann T, Redfield MM, Werdan K, Mitchell GF, Rice K, Arnett DK, Hofman A, Gottdiener JS, Uitterlinden AG, Meitinger T, Blettner M, Friedrich N, Wang TJ, Psaty BM, Van Duijn CM, Wichmann HE, Munzel TF, Kroemer HK, Benjamin EJ, Rotter JI, Witteman JC, Schunkert H, Schmidt H, Volzke H, Blankenberg S. Genetic variants associated with cardiac structure and function: a meta‐analysis and replication of genome‐wide association data. JAMA. 2009; 302: 168–178. - PMC - PubMed
-
- Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1‐ and alpha2C‐adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002; 347: 1135–1142. - PubMed
-
- Canham RM, Das SR, Leonard D, Abdullah SM, Mehta SK, Chung AK, Li JL, Victor RG, Auchus RJ, Drazner MH. Alpha2cDel322‐325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume. J Am Coll Cardiol. 2007; 49: 274–276. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous